| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |